A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity
To evaluate the different use way of intrarectal Amifostine administration on acute
radiation-induced rectal toxicity in pre-operative chemo-radiotherapy.
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Acute radiation-induced toxicity: daily diarrhea frequency
about 3 months from chemo-raditherapy to operation
No
Jing Jin, M.D
Principal Investigator
Chinese Acedemy of Medical Scinences
China: Ministry of Health
CH-GI-022
NCT01586117
February 2012
December 2014
Name | Location |
---|